Show simple item record

dc.contributor.authorBowyer, Sen_US
dc.contributor.authorPrithviraj, Pen_US
dc.contributor.authorLorigan, Pen_US
dc.contributor.authorLarkin, Jen_US
dc.contributor.authorMcArthur, Gen_US
dc.contributor.authorAtkinson, Ven_US
dc.contributor.authorMillward, Men_US
dc.contributor.authorKhou, Men_US
dc.contributor.authorDiem, Sen_US
dc.contributor.authorRamanujam, Sen_US
dc.contributor.authorKong, Ben_US
dc.contributor.authorLiniker, Een_US
dc.contributor.authorGuminski, Aen_US
dc.contributor.authorParente, Pen_US
dc.contributor.authorAndrews, MCen_US
dc.contributor.authorParakh, Sen_US
dc.contributor.authorCebon, Jen_US
dc.contributor.authorLong, GVen_US
dc.contributor.authorCarlino, MSen_US
dc.contributor.authorKlein, Oen_US
dc.date.accessioned2017-05-08T09:28:01Z
dc.date.issued2017-04en_US
dc.identifier.citationBritish journal of cancer, 2017, 116 (8), pp. e15 - ?en_US
dc.identifier.issn0007-0920en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/636
dc.identifier.eissn1532-1827en_US
dc.identifier.doi10.1038/bjc.2017.59en_US
dc.formatPrint-Electronicen_US
dc.format.extente15 - ?en_US
dc.languageengen_US
dc.language.isoengen_US
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_US
dc.subjectHumansen_US
dc.subjectMelanomaen_US
dc.subjectSkin Neoplasmsen_US
dc.subjectCTLA-4 Antigenen_US
dc.subjectProgrammed Cell Death 1 Receptoren_US
dc.subjectIpilimumaben_US
dc.titleReply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''.en_US
dc.typeJournal Article
rioxxterms.versionofrecord10.1038/bjc.2017.59en_US
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by-nc-sa/4.0en_US
rioxxterms.licenseref.startdate2017-04en_US
rioxxterms.typeJournal Article/Reviewen_US
dc.relation.isPartOfBritish journal of canceren_US
pubs.issue8en_US
pubs.notes12 monthsen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Melanoma and Kidney Cancer
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Melanoma and Kidney Cancer/Melanoma and Kidney Cancer (hon.)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublisheden_US
pubs.volume116en_US
pubs.embargo.terms12 monthsen_US
icr.researchteamMelanoma and Kidney Canceren_US
dc.contributor.icrauthorLarkin, Jamesen_US
dc.contributor.icrauthorMarsden,en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record